Bolt Biotherapeutics Stock Forecast - Accumulation Distribution
| BOLT Stock | USD 6.71 0.38 5.36% |
Bolt Stock outlook is based on your current time horizon.
At this time, The RSI of Bolt Biotherapeutics' share price is at 57 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Bolt Biotherapeutics, making its price go up or down. Momentum 57
Buy Extended
Oversold | Overbought |
EPS Estimate Next Quarter (5.40) | EPS Estimate Current Year (23.67) | EPS Estimate Next Year (20.24) | Wall Street Target Price 22 | EPS Estimate Current Quarter (5.39) |
Using Bolt Biotherapeutics hype-based prediction, you can estimate the value of Bolt Biotherapeutics from the perspective of Bolt Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Bolt Biotherapeutics after-hype prediction price | USD 6.94 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Bolt Biotherapeutics to cross-verify your projections. Bolt Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Bolt price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Bolt using various technical indicators. When you analyze Bolt charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Accumulation Distribution | Accumulation Distribution | Trend |
| 1204.45 | 2971.52 |
| Check Bolt Biotherapeutics Volatility | Backtest Bolt Biotherapeutics | Information Ratio |
Bolt Biotherapeutics Trading Date Momentum
| On January 28 2026 Bolt Biotherapeutics was traded for 6.71 at the closing time. The top price for the day was 7.11 and the lowest listed price was 6.66 . The trading volume for the day was 47 K. The trading history from January 28, 2026 did not affect price variability. The overall trading delta against the current closing price is 5.66% . |
Accumulation distribution indicator can signal that a trend is either nearing completion, at a continuation, or is about to break-outs. The actual value of this indicator is of no significance. What is significant is the change in value of over time. The formula for A/D of a given trading day can be expressed as follow: ((Close - Low) - (High - Close)) / (High - Low) X Volume
| Compare Bolt Biotherapeutics to competition |
Other Forecasting Options for Bolt Biotherapeutics
For every potential investor in Bolt, whether a beginner or expert, Bolt Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Bolt Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Bolt. Basic forecasting techniques help filter out the noise by identifying Bolt Biotherapeutics' price trends.Bolt Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Bolt Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Bolt Biotherapeutics could also be used in its relative valuation, which is a method of valuing Bolt Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Bolt Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Bolt Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Bolt Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Bolt Biotherapeutics stock market strength indicators, traders can identify Bolt Biotherapeutics entry and exit signals to maximize returns.
Bolt Biotherapeutics Risk Indicators
The analysis of Bolt Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Bolt Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bolt stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.15 | |||
| Semi Deviation | 3.71 | |||
| Standard Deviation | 4.18 | |||
| Variance | 17.47 | |||
| Downside Variance | 16.78 | |||
| Semi Variance | 13.79 | |||
| Expected Short fall | (3.49) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Bolt Biotherapeutics
The number of cover stories for Bolt Biotherapeutics depends on current market conditions and Bolt Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Bolt Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Bolt Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Bolt Biotherapeutics Short Properties
Bolt Biotherapeutics' future price predictability will typically decrease when Bolt Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Bolt Biotherapeutics often depends not only on the future outlook of the potential Bolt Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bolt Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.2 M | |
| Cash And Short Term Investments | 47.3 M |
Additional Tools for Bolt Stock Analysis
When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.